Pharma major Lupin has been granted an extension to set up its state-of-the-art formulation manufacturing unit at the MIHAN Special Economic Zone (SEZ) in Nagpur from the Commerce Ministry. However, a final call on the matter is yet to be taken by the Board of Approval (BoA) for SEZs.
Lupin had sought the extension on the grounds that it is yet to receive approvals from the US Food and Drug Administration (USFDA) for drugs that are to be produced at the unit. The company received the letter-of-permission (LoP) for setting up its unit in the MIHAN SEZ in April 2012, but has not been able to start commercial operations.
Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, APIs and biotechnology products.
